加拿大Tekmira 
加拿大RNAi专业公司Tekmira

Tekmira is an emerging leader in the advancement of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi).

In May 2008, Tekmira and Protiva Biotherapeutics combined their businesses to create a company with broad RNAi delivery technology and intellectual property, a deep product pipeline, significant partners and a strong balance sheet. Learn more about the Protiva business combination.